TW200914425A - Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast - Google Patents
Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast Download PDFInfo
- Publication number
- TW200914425A TW200914425A TW097126605A TW97126605A TW200914425A TW 200914425 A TW200914425 A TW 200914425A TW 097126605 A TW097126605 A TW 097126605A TW 97126605 A TW97126605 A TW 97126605A TW 200914425 A TW200914425 A TW 200914425A
- Authority
- TW
- Taiwan
- Prior art keywords
- vinyl
- phenyl
- group
- formula
- scope
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 29
- 150000003509 tertiary alcohols Chemical class 0.000 title abstract description 5
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229960005127 montelukast Drugs 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title description 7
- 230000008569 process Effects 0.000 title description 6
- 238000003786 synthesis reaction Methods 0.000 title description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 12
- -1 methylmagnesium halide Chemical class 0.000 claims abstract description 9
- 239000007818 Grignard reagent Substances 0.000 claims abstract description 8
- 150000004795 grignard reagents Chemical class 0.000 claims abstract description 8
- 150000002596 lactones Chemical class 0.000 claims abstract description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 30
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 19
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 17
- 229920002554 vinyl polymer Polymers 0.000 claims description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 6
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 238000002309 gasification Methods 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 229950009195 phenylpropanol Drugs 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000012442 inert solvent Substances 0.000 claims description 3
- 150000004682 monohydrates Chemical class 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims 1
- PUNXVEAWLAVABA-UHFFFAOYSA-N 1,2,3,4-tetrahydroanthracene;1,2,5,6-tetrahydroanthracene Chemical compound C1=CC=C2C=C(CCCC3)C3=CC2=C1.C1=CCCC2=C1C=C1CCC=CC1=C2 PUNXVEAWLAVABA-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- XBDYBAVJXHJMNQ-UHFFFAOYSA-N Tetrahydroanthracene Natural products C1=CC=C2C=C(CCCC3)C3=CC2=C1 XBDYBAVJXHJMNQ-UHFFFAOYSA-N 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 150000007942 carboxylates Chemical class 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- JNTDLFKBNBKNRI-UHFFFAOYSA-L dichloroantimony Chemical compound Cl[Sb]Cl JNTDLFKBNBKNRI-UHFFFAOYSA-L 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- ATYBXHSAIOKLMG-UHFFFAOYSA-N oxepin Chemical compound O1C=CC=CC=C1 ATYBXHSAIOKLMG-UHFFFAOYSA-N 0.000 claims 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 claims 1
- 125000003198 secondary alcohol group Chemical group 0.000 claims 1
- ZSHIDKYITZZTLA-XNTDXEJSSA-N 1-[3-[(e)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propan-1-ol Chemical compound CC(C)(O)C1=CC=CC=C1CCC(O)C1=CC=CC(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)=C1 ZSHIDKYITZZTLA-XNTDXEJSSA-N 0.000 abstract 1
- 150000002601 lanthanoid compounds Chemical class 0.000 abstract 1
- ICAKDTKJOYSXGC-UHFFFAOYSA-K lanthanum(iii) chloride Chemical compound Cl[La](Cl)Cl ICAKDTKJOYSXGC-UHFFFAOYSA-K 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 10
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical group COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- DAMJCWMGELCIMI-UHFFFAOYSA-N benzyl n-(2-oxopyrrolidin-3-yl)carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC1CCNC1=O DAMJCWMGELCIMI-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- OROGUZVNAFJPHA-UHFFFAOYSA-N 3-hydroxy-2,4-dimethyl-2H-thiophen-5-one Chemical compound CC1SC(=O)C(C)=C1O OROGUZVNAFJPHA-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 229910052761 rare earth metal Inorganic materials 0.000 description 2
- 150000002910 rare earth metals Chemical class 0.000 description 2
- 125000003396 thiol group Chemical class [H]S* 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- FOGXYSBGTKEZHG-UHFFFAOYSA-N 1,3-diphenylpentan-3-ol Chemical compound C=1C=CC=CC=1C(O)(CC)CCC1=CC=CC=C1 FOGXYSBGTKEZHG-UHFFFAOYSA-N 0.000 description 1
- SXFHKHHUPTWLFX-UHFFFAOYSA-N 1-tert-butyl-1-methylhydrazine Chemical compound CN(N)C(C)(C)C SXFHKHHUPTWLFX-UHFFFAOYSA-N 0.000 description 1
- HXZUUPAHSHVFDZ-UHFFFAOYSA-N 2-methyl-2-sulfanyloxypropane Chemical compound CC(C)(C)OS HXZUUPAHSHVFDZ-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229910004664 Cerium(III) chloride Inorganic materials 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- MQRMMPZMPBGBNO-UHFFFAOYSA-N NN.CCCCCCC Chemical compound NN.CCCCCCC MQRMMPZMPBGBNO-UHFFFAOYSA-N 0.000 description 1
- GPIXXWPSFWSNKE-UHFFFAOYSA-L S[Mg]Cl Chemical compound S[Mg]Cl GPIXXWPSFWSNKE-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- XKLVLDXNZDIDKQ-UHFFFAOYSA-N butylhydrazine Chemical compound CCCCNN XKLVLDXNZDIDKQ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- VYLVYHXQOHJDJL-UHFFFAOYSA-K cerium trichloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000005837 enolization reaction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000005272 metallurgy Methods 0.000 description 1
- YSTQWZZQKCCBAY-UHFFFAOYSA-L methylaluminum(2+);dichloride Chemical compound C[Al](Cl)Cl YSTQWZZQKCCBAY-UHFFFAOYSA-L 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- SYXYWTXQFUUWLP-UHFFFAOYSA-N sodium;butan-1-olate Chemical compound [Na+].CCCC[O-] SYXYWTXQFUUWLP-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- DUYAAUVXQSMXQP-UHFFFAOYSA-M thioacetate Chemical compound CC([S-])=O DUYAAUVXQSMXQP-UHFFFAOYSA-M 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
200914425 九、發明說明: 【發明所屬之技術領域】 本發明係關於製備其式如下的三級醇之方法
此三級醇亦即’ α-[3-[(ΐΕ)-2-(7-氯-2-喹啉基)乙烯基] 苯基]-2-(1-經基-丨-曱基乙基)苯丙醇,其(aS)-鏡像異構物 在 被稱為 蒙特 硫卡酸 (monkhkasOG-UIXlR)-卜[3-[(1Ε)-2-(7-氯-2-喹啉基)乙烯 基]苯基]-3-[2-(l-羥基-丨―甲基乙基)苯基]丙基]硫代]曱基] 環丙醋酸)之藥用活性化合物之合成中,是一種關鍵的中間 物。進一步係關於該方法之新穎的中間物及用於彼之製備 ί 之方法。 【先前技術】 (a S)- α -[3-[(1Ε)-2-(7-氣-2-喹啉基)乙烯基]苯 基]-2-(1-經基_丨_甲基乙基)苯丙醇之已知的合成方法係基於 緩酸醋與二當量的格林納(Grignard )試劑之反應。但是, 因為所不欲的反應與酵之形成競爭並形成副產物,所以, 產率通吊無法令人滿意’在使用烧基氣化鎮作為格林納試 ^ 時更疋如此(D.A.Conlon 等人,di/v.办《ί/?. Caia/. 2004 200914425 346, 13〇7-1315)。已經發現”幾乎無水,,之經活化的三氯化鈽 對於前述反應具有有利的影響,曾假設此因抑制酮中間物 之烯醇化反應之故。已經知道三氯化鈽的水含量和活化方 法及其結晶特性非常關鍵。此外,氣化鈽之活化方法有些 繁瑣且經活化的氯化鈽幾乎不溶於醚製的溶劑(如,四氫呋 喃)中,此得到非均相的反應混合物。在前述蒙特硫卡酸中 間物之製備中,起始物(其可以單水合物形式使用)必須先被 小心地乾燥(如,藉共沸蒸餾法),否則,需要約5當量的甲 基氯化鋁,而非理論量的3當量(w〇95/181〇7 Ai)。 WO 2007/057225 Α2 揭示製備(aR)_a_[3_[(1E)_2_(7_ 氯-2-啥琳基)乙浠基]苯基經基·卜甲基乙基)苯丙硫 醇(I的硫代同系物)之方法。此合成始自2_[(3s)_ 3-[3-[(1Ε)·2·(7-氯·2_㈣基)乙稀基]苯基]_3•經丙基]苯甲 酸甲西旨#水合物(參考下文的式_其先藉共沸脫水反應 轉化成無水形式,之德盆—ύη X-*- Art ^ 伖^ 一級醇部分甲磺酸化,之後藉 由與硫代醋酸之反應而錯_ $丨丨油丄^ , 您向付到相對應的硫代醋酸酯,其於之 後與甲基鹵化鎂反應而得到 ^ 』ε硫代内酯。此硫代内酯與甲 基氣化鎂和氣化鈽(ΙΠ)及雇&括μ 一上 ()夂應而得到所欲之具有二級硫醇基 的二級醇。此合成需要四個 = 久應步驟和共沸脫水處理且, 在最後一個步驟中,需要相讲。& $要超過3莫耳的氯化鈽(III)/莫耳硫 代内S旨。 【發明内容】 本發明的一個目的是要想山占上 I徒出自相對應的羧酸酯和格林 納試劑製備三級醇α Ε) U Μ 2-(7·氯-2-喹啉基)乙烯基]笨 200914425 基]-2-(1-羥基-1-曱基乙基)苯丙醇(I)之改良方法,其以高產 率提供所欲產物,即使使用格林納試劑的氯化物形式亦 然。此方法應不包含繁瑣的活化步驟、大量的稀土金屬化 合物、不均勻的反應混合物或麻煩的處理程序。 申請人已發現,所欲產物可以簡便地藉由使其式如下 的内酯
即’ 3-[3-[(E)-2-(7-氣-2-喹啉基)乙烯基]苯基]_4,5_二氫 -3H-苯並[c]°惡更英(〇xepin)-l-酮, 與下式的格林納試劑 CH3MgX (III), 其中X是乳、溴或峨, 在崎製的溶劑中’在三氣化鑭和氯化鋰存在時反應而 製得。 應瞭解所謂的”醚製的溶劑”包括任何包含實質量之於 反應度為液體的非環狀或環狀醚之溶劑或溶劑混合物, 如一乙醚、—丁趟、甲基第三丁基趟、二甲氧基乙貌、 200914425 四氫呋喃(THF)、1,4-二噁烷和類似者。其亦包括環狀乙縮 搭’如 ’ 1,3-二氧戊環(i,3_di〇x〇lane:^ 丨,3_二噁烷。 氯化鋰使三氯化鑭安定,得到兩種鹽在醚製的溶劑中 之真實溶液並因此而為均勻的反應混合物。在一較佳具體 實例中,三氯化鑭和氯化鋰以丨:2或較低的莫耳比存在。 LaC〗3和LiCl之莫耳比為1. 2的四氫夫π南溶液可以商業方
式自德國法蘭克福(Frankfurt (Main))的 Chemetall GmbH 取得。 格林納試劑III中的鹵素組份X以氣為佳。 最佳地’前述結構I和II中的二級醇基和噁更英環的 位置3的碳原子分別具有8構形,以使得其適合作為合成 (R)-蒙特硫卡酸之中間物。 本發明之方法中使用之醚製的溶劑以僅使用四氫吱喃 或四氫°夫喃和惰性溶劑(如,脂族或芳族烴)之混合物為佳。 反應溫度可以在格林納反應常用的範圍内,以介於_2〇 C和室溫之間為佳,由-10°C至+1 〇°C更佳。 根據此技術中常用之方法,反應混合物之處理可藉, 士 以水或含水的弱酸中止反應及以適當溶劑萃取此產 物,而完成。 根據本發明之方法之特別的優點在於相對於習慣用來 作為起始物的羥基酯(請參考WO 95/18107A1),内酯π沒 有活丨生氫來消耗另一當量的格林納試劑。另一優點在於所 需的氯化鑭的量實質上低於先前技術的方法中所用之氯化 飾的量。先前技術之方法使用的三氣化鈽之莫耳比為CeCl3 200914425 /羥基酯起始物約丨: 而本發明之^方、土 的三氯化鑭/内酯草且^(方去可以實質上較低 、斗比進行。由於含古 廢料的量之減少相奋日日3有鎮和稀土金屬的 面特別有利。 、汉應此合物之處理方 一較佳具體實例φ ^ 二氯化鑭/内酿莫耳μ_人从 和1 : 1 〇之間,介於,. 响吴耳比介於1 : 2 .R . ^ t ? . 3和1 : 5之間更佳。 式II的内酯為新 ㈣員的化合物2亦為本發 一較佳且體眚a,丄 十奴乃I 的。 貫例中,内酯II的》亞更笨产认 碳原子具有S構形。 心更央裱的位置3 t的 本發明的進-步目的為製備内 異地發現,當其式& 方法。申鲕人訝 田丹式如下的羧酸酯
、中R疋c丨-丨0烷基、芳基或芳烷基, 與下式的格林納試劑 (V) R^gci 其中Rl是Cl-4烷基, 製的溶劑中,纟無關化合物(如,氯化飾或鑭) 200914425 存在時反應時,以高選擇性地得到此化合物。 一較佳具體實例中,R1是甲基。 應瞭解的是,此處所謂的”Cl.n烷基,,意欲包含任何具有 1至η個碳原子之直鏈或支鏈的烷基。例如,所謂的” 烷基”包含甲基、乙基、丙基、異丙基、丁基、異丁基、1第 二丁基和第三丁基。除了前述者之外,所謂的”^院基” 所包含的基團如戊基、異戊基、新戊基、己基、異己基、 庚基、辛基、壬基、癸基和類似者。
包含至少一個芳環 、萘基、蒽基、菲 ’’芳基”的較佳意義 應瞭解所謂的,,芳基,,意欲包含任何 的一―、二-或多碳環基團,如,苯基 基、聯苯基、苐基、四氫萘基和類似者。 是苯基。 —應瞭解所謂的基,,包含絲。特別是CM燒基盆 _述”職”中所述之基團之—取代。芳燒基的最佳意義是 本甲基。 ^亦為本發明之目的的另-方法中,内醋„可藉由使叛 酸酿IV與強驗(如’驗金屬或驗土金屬之{氧化物)反 應而製得。較㈣Cl.4烧氧化物是第三丁氧化物,特別是 第二丁氧化鈉、舒或鎂。 —較佳的具體實例中,賴部分的基團厌是曱基。 更佳地’此曱酯以一水合物形式傕 切办式便用。式II中的噁更 央衣的位置3的碳原子和式IV中的-纽 ^ ^ 八 中的一級醇基二者皆以S構 【實施方式】 11 200914425 將以下列非限制實施例說明本發明β 實施例1 (38)-3-[3_[(1:)_2_(7_氣_2_喳啉基)乙烯基】苯基】_45二氫 -3Η-苯並[c]«更英酮 2- [(3S)-3-[3-[(lE)-2-(7-氣-2-喹啉基)乙烯基]苯基]_3_ 羥丙基]苯甲酸甲酯一水合物(18_32克,38·5毫莫耳)於6〇 升THF和210毫升曱苯中之懸浮液在25〇毫升雙重護套 的反應器中於氮下冷卻至-5。(:。曱基氯化鎂(於THF中之3M 溶液,53·4毫升,160毫升)於25分鐘期間内逐滴添加並使 得溫度維持於-5。(:。此棕色懸浮液於攪拌4小時及於2〇 °C攪拌24小時。15分鐘之内,此反應混合物加至已預冷至 5 C的2M含水醋酸中。此添加期間内,溫度升至丨2它。此 混合物再於此溫度攪拌5分鐘,並分離各相。丟棄含水相, 有機相以10%含水的碳酸鈉溶液清洗,之後以1%含水的碳 酸鈉溶液清洗(各320毫升)。此溶液在真空中(4〇。〇,3〇毫 巴)蒸發’得到24克殘渣,其溶解於45°C的THF (15毫升) 中。庚烧(4 1毫升)逐滴添加至此溶液。所形成的懸浮液冷 卻至0 C,過濾,以庚烷(30毫升)清洗並乾燥,得到8.57 克的灰棕色的固體。
熔點:160°C IR (KBr): v = 2931, 1714, 1608, 1497, 1455, 1410, 1297, 1251, 1121, 1084, 1039, 927, 875,832, 799, 774, 755,731,693 cm-1 'H NMR (DMSO-d6, 500 MHz): δ = 2.28 (m, 1H), 2.45 12 200914425 (m, 1H), 2.98 (m, 1H), 3.04 (m, 1H), 5.17 (dd, J = 12.2, 4.9 Hz; 1H), 7.45 (m, 3H), 7.49 (m, 1H), 7.52 (d, J = 16.6 Hz, 1H), 7.58 (dd, J= 8.8, 1.9 Hz; 1H), 7.63 (t, J= 7.5 Hz, 1H), 7.68 (m, 1H), 7.71 (d, J = 7.3 Hz, 1H), 7,85 (s, 1H), 7.87 (d, J= 16.6 Hz, 1H), 7.88 (d, J= 8.8 Hz, 1H), 7.98 (d, J = 8.8 Hz, 1H), 8.0 (d, J = 1.5 Hz, 1H), 8.38 (d, J = 8.8 Hz, 1H). 13C NMR (DMSO-d6, 126 MHz): δ=29.24, 35.29, 78.86, 120.28, 125.20, 125.55, 126.61, 126.81, 127.16, 127.28, 128.71, 128.89, 128.97, 129.66, 129.80, 131.42, 132.66, 134.25, 134.48, 136.20, 136.49, 137.60, 139.81, 147.96, 156.61,170.01. 實施例2 (a S)- α -[3-[(lE)-2-(7-氣-2-喹啉基)乙烯基】苯基】_2_(1_樂 基-1-甲基已基)苯丙醇 (3S)-3-[3-[(E)-2-(7-氣-2-喹啉基)乙烯基]苯基]_4,5_ 二 氳-3H-苯並[c]°惡更英-1-嗣(3.05克,7.2毫莫耳)於THF (45 毫升)中之溶液在250毫升雙重護套的反應器中於氮下冷卻 至5°C。添加甲基氯化鎂(於THF中之3M溶液,7.11克, 21·〇毫莫耳)。氣化鋼/氣化鐘(莫耳比1 : 2,於THF中之 16。/。溶液,3.23克’ 1.6毫莫耳)於5。(:攪拌時添加。此反應 混合物加熱至20°C並於此溫度再攪拌1小時。以HPLC監 測確保反應完全。此溶液冷卻至低於丨〇它,2M含水的醋酸 (5 0毫升)以5分鐘添加,之後添加曱基第三丁基醚(5〇毫 13 200914425 升)°各相分離且有機相先後以1 0%含水的碳酸鈉溶液(50 毫升)和飽和的鹽水(50毫升)清洗。此有機相在真空(4(rc, 280毫巴)中濃縮至重量為6 83克。庚烷〇 7毫升)於2Γ(: 以一小時逐滴添加至此殘渣中,之後,此懸浮液冷卻至〇 °C並攪拌1小時。沉澱物經過濾,以庚烷(1〇毫升)清洗和 於真空中於30°C乾燥,得到2.31克淡灰棕色粉末,純度 (HPLC) 94.9%。 'H NMR (DMSO-d6, 500 MHz): δ= 1.51 (s, 3H); 1.52 (s, 3H); 2.00 (m, 2H), 2.96 (m, 1H); 3.10 (m, 1H); 4.72 (m, 1H); 4.94 (s, 1H); 5.36 (d, J= 4.4 Hz, 1H); 7.09 (t, J= 7.6 Hz, 1H); 7.14 (t, J= 7.8 Hz, 1H); 7.18 (d, J= 6.4 Hz, 1H); 7.41 (m, 2H); 7.44 (d, J- 7.9 Hz, 1H); 7.49 (d, J= 16.6 Hz, 1H); 7.56 (dd, J= 8.3, 2.2 Hz, 1H); 7.62 (d, J= 6.8 Hz, 1H); 7.77 (bs, 1H); 7.91 (d, J= 16.6 Hz, 1H); 7.92 (d, J= 8.7 Hz, 1H); 7.99 (d, J= 8.8 Hz, 1H); 8.03 (d, J= 2.0 Hz, 1H); 8.38 (d, J= 8.4 Hz, 1H). 13C NMR (DMSO-d6, 126 MHz): δ = 29.82, 31.55, 31.57, 42.34, 71.60, 72.31, 120.24, 124.73, 124.88, 125.24, 125.51, 125.71, 126.22, 126.54, 127.16, 128.04, 128.49, 129.65, 130.82, 134.23, 135.20, 135.67, 136.43, 140.25, 146.66, 146.93, 147.99, 156.78. 實施例3 (3S)-3-[3-[(E)-2-(7-|L -2-喳啉基)乙烯基]苯基】_4,5_ 二 200914425 氫-3H-苯並[C】嘬更英-1*5 在 250 毫升瓶中,2-[(3S)- 3-[3-[(lE)-2、(7_氣 乙烯基]苯基]-3-羥丙基]苯甲酸甲酯一八、2喹啉基) 八σ物(9.4 * , 20毫 莫耳)懸浮於甲苯(1〇〇毫升)中並加熱至迴兄。宅 1 1 0 C 、 j 下 常壓力下,自此溶液蒸餾52毫升的溶劑。 _ , Λ 彳卞爾費雪分析顯
示此溶液的水含Ϊ為0.023%(取出i毫升溶液)。4埃分子篩 ?克)加至此溶液中。之後,添加第三丁氧化鎮(7.ϋ 毫莫耳)。此反應混合物於約2(rc攪拌且同時以監 測。反應完全之後,添加THF (20毫升)和水(5毫升)以中止 此反應。固體經職並以THF (3G毫升)清洗。澹液濃縮至 3〇毫升。於攪拌時,逐滴添加正庚烷(2〇毫升),之後,將 所形成的懸浮液冷卻至〇。(:。固體產物經濾出並於25°c於 真空下乾燥。 產率:5.2 克(61.8%),純度(HPLC)98.8%。 【圖式簡單說明】 無 【主要元件符號說明】 益 15
Claims (1)
- 200914425 十、申請專利範固: 1 ·—種製備下式之[3-[(1E)-2_(7-氣-2-喹啉基)乙烯基] 苯基]-2-(ι_羥基-丨甲基乙基)苯丙醇之方法其藉由使下式的内酯3-[3-[(E)-2-(7-氯-2-喹啉基)乙烯 基]本基]·4,5 -二氫- 3H-苯並[c]e惡更英(oxepin)-l -酮(Π) 與格林納(Grignard )試劑 CH3MgX (III), 其中X是氯、溴或碘, 200914425 在喊製的溶劑中,方=备 2 iP Μ 在二氯化鑭和氯化鋰存在時反應。 •根據申句專利範圍第!項 化裡以莫耳比為j:2存在。 ★其中二氣化鋼和氣 3_根據申請專利範圍第1或 4.根據申請專利範圍第…方法,其中X疋氣。 j靶固第1或2項之方法, 級醇基和噁更英環的位 、 ,一 ,. 罝3中的碳原子具有S構形。 .根據申知專利範圍第 劑是四氫咬喃或四氫咬喃和盘:貞之方法,其中_製的溶 夫喃和與惰性溶劑之混合物。 6·根據申請專利範圍第 與内_)的莫耳比由i 9 項之方法,其中三氯化鑭 7. 根據申請專利範 酯(II)的莫耳比由!: 之方法,其中三氯化鋼與内 土 1 · 5 〇 8. —種其式如下的39.根據申請專利範圍第 項之化合物,盆為jSl -V、ίγ的 (3S)-3-[3-[⑻-2_(7_ 氣·2 ” 為,、式如下的 ^ -rf Γ 1 S ® - 噯啉基)乙烯基]苯基]-4,5-二氫 -3H-本並[c]噁更英, 17 2009144251〇_—種製備下式的3-[3-[(E)-2-(7-氯-2-喹啉基)乙烯基] 苯基]-4,5-二氫-3H-苯並[c]噁更英-1-酮之方法(Π), 包含使其式如下的羧酸酯其中R是(:!_!〇烷基、芳基或芳烷基, 與下式的格林納試劑 18 200914425 (V), R'MgCl 其中R1是Cw烷基, 在醚製的溶劑中,在無類鑭化合物存在時反應。 11. 根據申請專利範圍第10項之方法,其中R1是甲基。 12. —種製備下式的3-[3-[(E)-2-(7-氯-2-喹啉基)乙烯基] 苯基]-4,5-二氳-3H-苯並[c]噁更英-1-酮之方法(II),包含使其式如下的羧酸酯(IV), 其中R是ChM烷基、芳基或芳烷基, 與強驗反應。 19 200914425 * 13. 根據申請專利範圍第12項之方法,其中強鹼是鹼金 屬或驗土金屬的C】_4-烧氧化物。 14. 根據申請專利範圍第10至13項中任一項之方法, 其中R是甲基。 15. 根據申請專利範圍第14項之方法,其中羧酸酯IV 為單水合物形式。 16. 根據申請專利範圍第10或12項之方法,其中式II 中的噁更英環的位置3的碳原子和式IV中的二級醇基具有 f S構形。 17. 根據申請專利範圍第10或12項之方法,其中醚製 的溶劑是四氫°夫喃或四氫呋喃和惰性溶劑之混合物。 十一、圖式: 無 20
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07013810A EP2014650A1 (en) | 2007-07-13 | 2007-07-13 | Process and intermediate for the production of an intermediate in the production of montelukast |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200914425A true TW200914425A (en) | 2009-04-01 |
Family
ID=38786992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW097126605A TW200914425A (en) | 2007-07-13 | 2008-07-14 | Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100190987A1 (zh) |
| EP (2) | EP2014650A1 (zh) |
| JP (1) | JP2010533207A (zh) |
| KR (1) | KR20100044844A (zh) |
| CN (1) | CN101808997A (zh) |
| AT (1) | ATE531694T1 (zh) |
| AU (1) | AU2008277938A1 (zh) |
| BR (1) | BRPI0814526A2 (zh) |
| CA (1) | CA2692896A1 (zh) |
| EA (1) | EA201000099A1 (zh) |
| TW (1) | TW200914425A (zh) |
| WO (1) | WO2009010230A2 (zh) |
| ZA (1) | ZA201000238B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116332220B (zh) * | 2023-05-29 | 2023-08-11 | 研峰科技(北京)有限公司 | 一种氯化镧(iii)双(氯化锂)的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266568A (en) * | 1990-10-12 | 1993-11-30 | Merck Frosst Canada, Inc. | Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| AR056815A1 (es) * | 2005-11-18 | 2007-10-24 | Synthon Bv | PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST |
-
2007
- 2007-07-13 EP EP07013810A patent/EP2014650A1/en not_active Withdrawn
-
2008
- 2008-07-10 WO PCT/EP2008/005637 patent/WO2009010230A2/en not_active Ceased
- 2008-07-10 CA CA 2692896 patent/CA2692896A1/en not_active Abandoned
- 2008-07-10 JP JP2010516405A patent/JP2010533207A/ja not_active Withdrawn
- 2008-07-10 EP EP08773959A patent/EP2178841B1/en active Active
- 2008-07-10 KR KR1020107003157A patent/KR20100044844A/ko not_active Withdrawn
- 2008-07-10 AU AU2008277938A patent/AU2008277938A1/en not_active Abandoned
- 2008-07-10 EA EA201000099A patent/EA201000099A1/ru unknown
- 2008-07-10 CN CN200880024396A patent/CN101808997A/zh active Pending
- 2008-07-10 AT AT08773959T patent/ATE531694T1/de active
- 2008-07-10 US US12/668,320 patent/US20100190987A1/en not_active Abandoned
- 2008-07-10 BR BRPI0814526-1A2A patent/BRPI0814526A2/pt not_active IP Right Cessation
- 2008-07-14 TW TW097126605A patent/TW200914425A/zh unknown
-
2010
- 2010-01-12 ZA ZA201000238A patent/ZA201000238B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2178841B1 (en) | 2011-11-02 |
| ATE531694T1 (de) | 2011-11-15 |
| EP2014650A1 (en) | 2009-01-14 |
| WO2009010230A3 (en) | 2009-04-23 |
| KR20100044844A (ko) | 2010-04-30 |
| EP2178841A2 (en) | 2010-04-28 |
| AU2008277938A1 (en) | 2009-01-22 |
| CA2692896A1 (en) | 2009-01-22 |
| EA201000099A1 (ru) | 2010-06-30 |
| WO2009010230A2 (en) | 2009-01-22 |
| ZA201000238B (en) | 2010-09-29 |
| JP2010533207A (ja) | 2010-10-21 |
| BRPI0814526A2 (pt) | 2015-01-27 |
| CN101808997A (zh) | 2010-08-18 |
| US20100190987A1 (en) | 2010-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI338003B (en) | Process for the manufacture of organic compounds | |
| HU226394B1 (en) | Process for the preparation of leukotriene antagonists and their salts | |
| HUP0302287A2 (hu) | Eljárás ciklopropánkarbonsav-észterek és származékaik előállítására | |
| WO2017076293A1 (zh) | 一种噁唑烷酮中间体的制备方法 | |
| KR101839634B1 (ko) | 수렴형 환원성 아미노화에 의한 페로퀸의 합성 방법 | |
| JP5531018B2 (ja) | モンテルカストナトリウム塩の製造方法 | |
| WO2008049922A2 (en) | A new process for the preparation of montelukast | |
| TW200914425A (en) | Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast | |
| CN115710221A (zh) | 一种孟鲁司特钠中间体的合成方法 | |
| TW200918492A (en) | Process for the production of tertiary alcohols | |
| US20090281323A1 (en) | Process for the manufacture of montelukast sodium | |
| CN1972901A (zh) | (z)-1-苯基-1-二乙氨基羰基-2-氨甲基环丙烷盐酸盐的制造方法 | |
| JP5796836B2 (ja) | ピタバスタチンまたはその塩の中間体の製造方法 | |
| WO2012004811A1 (en) | Process for the preparation of 5-substsituted indole derivative | |
| JP2013095752A (ja) | ペランパネルの中間体である2−アルコキシ−5−(ピリジン−2−イル)ピリジンの調製方法 | |
| CN107163021A (zh) | 一种锅法制备2‑噻吩乙醇磺酸酯的方法 | |
| JP6059157B2 (ja) | モンテルカスト中間体のカンファースルホン酸塩 | |
| KR100915666B1 (ko) | 광학적으로 순수한 (s)-3-히드록시피롤리딘의 제조방법 | |
| SK287721B6 (en) | Process for producing quinoline carboxyaldehyde derivative and intermediate thereof | |
| JP2007519660A (ja) | 2−(エトキシメチル)トロパン誘導体の製造方法 | |
| JP2023053768A (ja) | 光学活性カルボン酸の製造方法 | |
| WO2016147133A1 (en) | Process for the preparation of droxidopa | |
| KR20110134249A (ko) | 피타바스타틴 또는 그의 염의 중간체의 제조방법 | |
| TWI297006B (en) | Intermediate compounds for the preparation of cyclopropyl carboxylic acid esters and derivatives | |
| CN103387540B (zh) | 一种成盐法制备唑菌酯的方法 |